Model for predicting prognosis of lung squamous cell carcinoma with seven genes as biomarkers, and establishing method thereof
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- 辽宁省肿瘤医院
- Publication Date
- 2019-06-07
Smart Images
Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the field of gene technology and biomedicine, and specifically relates to a model containing seven genes as biomarkers to predict the prognosis of lung squamous cell carcinoma and a method for establishing it. Background technique
[0002] Squamous cell carcinoma of the lung, or squamous cell carcinoma of the lung, is one of the most important pathological types of lung cancer. It is derived from the malignant transformation of bronchial epithelial cells, and the number of cases accounts for about 30% of non-small cell lung cancer. Conventional treatment methods for lung squamous cell carcinoma mainly include surgical treatment, chemotherapy and molecular targeted therapy. The 5-year survival rate of patients is less than 15%, and more than 400,000 people die from it every year in the world. At present, there is no reference standard for the prognosis of patients with squamous cell carcinoma of the lung, and there is no specifi...